ロード中...
SIRT1 expression is associated with a poor prognosis, whereas DBC1 is associated with favorable outcomes in gastric cancer
Clinical trials of histone deacetylase (HDAC) inhibitors as antitumor therapy have been conducted for gastric cancer. Expression of SIRT1, a class III HDAC, is related to poor prognosis in some malignancies. We investigated the correlation between SIRT1 expression and progression and prognosis of ga...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Publishing Ltd
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4298382/ https://ncbi.nlm.nih.gov/pubmed/25146318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.310 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|